Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia
Journal of Infection and Public Health · 2025-08 · 18 (8) · 102829
DOI: 10.1016/j.jiph.2025.102829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025-08. Verfasst von Matthew Chung Yi Koh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: matthew.koh@mohh.com.sg. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Gram-Negative Bacterial Infections, Bacteremia, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Stenotrophomonas maltophilia is an important nosocomial pathogen. Bacteraemia is associated with significant morbidity, despite antibiotic therapy. Optimal treatment strategies for Stenotrophomonas maltophilia bacteraemia remain ill-defined. Thus, we retrospectively examined the clinical presentation, microbiological characteristics, treatment options to identify risk factors for mortality. METHODS: We performed a retrospective single-centre analysis of Stenotrophomonas maltophilia bacteraemia from 1 Jan 2012-30 Jun 2024. Data on the clinical presentation, source of infection, microbiological characteristics, treatment strategies and clinical outcomes were tabulated. Risk factors for in-hospital all-cause mortality were identified by appropriate univariate and multivariable analyses. RESULTS: There were 197 bacteraemia episodes. In-hospital mortality was 41.6 % (n = 82), and did not change significantly over the years. Patients who died were more likely to have prior carbapenem exposure (81.7 % vs 53.0 %, p < 0.001), presentation in an intensive care (ICU) setting (73.2 % vs 15.7 %, p < 0.001), and had a longer duration of fever (8.5 ± 2.5 vs 3.0 ± 3.8 days, p < 0.001). Microbiological isolation from additional sites other than the blood (e.g. sputum culture positivity) also correlated with mortality (39.0 % vs 7.8 %, p < 0.001). Over time, proportion of isolates resistant to fluoroquinolones increased. An initial antimicrobial choice containing trimethoprim-sulfamethoxazole appeared to be more likely to be associated with survival. Only 13 patients (6.6 %) received dual antibiotics initially, so it was unclear if this was associated with better outcomes. On multivariable analysis, ICU onset, elevated C-reactive protein, longer duration of fever and an absence of intervention for source control remained independently associated with mortality. CONCLUSIONS: Source control of infection may be critical in improving survival in Stenotrophomonas maltophilia bacteraemia. Future prospective studies should validate important risk factors for mortality and define optimal antimicrobial treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: matthew.koh@mohh.com.sg.
- Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: nicholas_ngiam@nuhs.edu.sg.
- Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic add…
- Department of Laboratory Medicine, National University Hospital, Singapore. Electronic address: Ka_lip_chew@nuhs.edu.sg.
Zitieren
APA
Koh, M. C. Y., Ngiam, J. N., Lum, L. H., Smitasin, N., Chew, K. L., & Allen, D. M. (2025). Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia. Journal of Infection and Public Health, 18(8), 102829. https://doi.org/10.1016/j.jiph.2025.102829
Vancouver
Koh MCY, Ngiam JN, Lum LH, Smitasin N, Chew KL, Allen DM. Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia. Journal of Infection and Public Health. 2025;18(8):102829. doi:10.1016/j.jiph.2025.102829
BibTeX
@article{Koh2025,
author = {Koh, Matthew Chung Yi and Ngiam, Jinghao Nicholas and Lum, Lionel Hon-Wai and Smitasin, Nares and Chew, Ka Lip and Allen, David Michael},
title = {Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia},
journal = {Journal of Infection and Public Health},
year = {2025},
volume = {18},
number = {8},
pages = {102829},
doi = {10.1016/j.jiph.2025.102829}
}
EUVIMED